Abstract

Hypertrophic obstructive cardiomyopathy (HOCM) has had a long history and many different names. Probably the first descriptions of HOCM were by Liouvielle in 1869 [1] and Hallopeau [2] in the same journal. Schminke [3] described severe hypertrophy of the septum in two patients in 1907. The disease then disappeared from view until revisited by Brock 50 years later [4], who described it as “functional obstruction of the left ventricle”, although Evans in 1949 [40] had reported familial cardiomegaly and Davies in 1952 [5] had described a family prone to sudden death, many members of which had systolic murmurs. One patient upon necropsy showed “diffuse subaortic stenosis”, associated with left ventricular hypertrophy [4, 5]. As pointed out by Roberts [6], no measurements of the comparative thickness of the septum were made in these cases and, therefore, the diagnosis must remain presumptive. In 1958 Teare [7] reported the pathological features of this disease and applied the descriptive title “asymmetrical hypertrophy of the heart”. In 1960 Braunwald and his colleagues in the United States of America described the condition as “idiopathic hypertrophic subaortic stenosis” (IHSS) [8], while in the same year in London Goodwin et al. [9], believing the disease to be more extensive than one merely producing outflow tract obstruction, called it “obstructive cardiomyopathy”. The importance of “hypertrophy”, rather than “obstruction”, led us to revise the name to “hypertrophic obstructive cardiomyopathy” [10].

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Liovillie H (1869) Retricissement cardiaque sous aortique. Gazette Med Paris 24: 161Google Scholar
  2. 2.
    Hallopeau M (1869) Retricissement ventriculo-aortique. Gazette Med Paris 24: 683Google Scholar
  3. 3.
    Schminke A (1907) Uberlinksartige musculose conenstenosen. Dtsch Med Wochenschr 33: 2082Google Scholar
  4. 4.
    Brock R (1957) Functional obstruction of the left ventricle (acquired subvalvar aortic stenosis). Guy’s Hospital Rep 106: 221Google Scholar
  5. 4a.
    Evans W (1949) Familial cardiomegaly. Br Med J 11: 68Google Scholar
  6. 5.
    Davies LC (1952) Familial heart disease. Br Heart J 14: 206PubMedGoogle Scholar
  7. 6.
    Roberts WC (1974) Asymmetric septal hypertrophy. Ann Intern Med 81: 650Google Scholar
  8. 7.
    Teare D (1958) Asymmetrical hypertrophy of the heart in young adults. Br Heart J 20: 1PubMedGoogle Scholar
  9. 8.
    Braunwald E, Morrow AG, Cornell WP, Aygen MM, Hilbish TF (1960) Idiopathic hypertrophic subaortic stenosis. Clinical, haemodynamic and angiographic manifestations. Am J Med 29: 924Google Scholar
  10. 9.
    Goodwin JF, Hollman A, Cleland WP, Teare D (1960) Obstructive cardiomyopathy simulating aortic stenosis. Br Heart J 22: 403PubMedGoogle Scholar
  11. 10.
    Cohen J, Effat H, Goodwin JF, Oakley CM, Steiner RE (1964) Hypertrophic obstructive cardiomyopathy. Br Heart J 26: 16PubMedGoogle Scholar
  12. 11.
    McMichael J (1964) Chairman’s introduction. In: Wolstenhome G, O’Connor M (eds) Cardiomyopathies. Ciby Foundation Symposium, Churchill, London, p 1Google Scholar
  13. 11a.
    WHO/ISFC (1982) Report of the WHO/ISFC task force on the definition and classifica-tion of cardiomyopathies. Br Heart J 44: 672–673Google Scholar
  14. 12.
    Olsen EGJ (1972) Cardiomyopathies: clinico-pathological correlations 1. In: Edwards, Brest (eds) Cardiovascular pathology. Davis, Philadelphia, p 240Google Scholar
  15. 13.
    Olsen EGJ (1971) Morbid anatomy and histology in hypertrophic obstructive cardio-myopathy. In: Wolstenhome, O’Connor (eds) Hypertrophic obstructive cardiomyopathy. Ciba Foundation Study Group, no 37. Churchill, London, p 183Google Scholar
  16. 14.
    Van Noorden S, Pearse AGE (1971) Histochemistry and electronmyocroscopy of the heart. In: Wolstenhome, O’Connor (eds) Hypertrophic obstructive cardiomyopathy. Ciba Fondation Study Group, no 37. Churchill, London, p 192Google Scholar
  17. 15.
    Ferrans VJ, Morrow AG, Roberts WC (1972) Myocardial ultrastructure in idiopathic hypertrophic subaortic stenosis. Circulation 45: 769PubMedGoogle Scholar
  18. 16.
    Maron BJ, Roberts WC (1979) Quantitative analysis of cardiac muscle cell disorganisation in the ventricular septum of patients with hypertrophic cardiomyopathy. Circulation 59: 689PubMedGoogle Scholar
  19. 16a.
    Becker AE, Caruso G (1982) Myocardial disarray - a critical review. Br Heart J 47: 527PubMedGoogle Scholar
  20. 17.
    Stewart S, Mason DR, Braunwald E (1963) Impaired rate of left ventricular filling in idiopathic hypertrophic subaortic stenosis and valvular aortic stenosis. Circulation 38: 8Google Scholar
  21. 18.
    Wigle ED (1964) Clinical aspects in 34 cases in cardiomyopathies. In: Wolstenholme G, O’Connor M (eds) Cardiomyopathies. Ciba Foundation symposium. Churchill, London, p 49Google Scholar
  22. 19.
    Swan DA, Bell B, Oakley CM, Goodwin JF (1971) Analysis of the symptomatic course and prognosis and treatment of hypertrophic obstructive cardiomyopathy. Br Heart J 33: 671PubMedGoogle Scholar
  23. 20.
    Webb-Peploe MM, Oakley CM, Croxson RS, Goodwin JF (1971) Cardioselective beta-adrenergic blockade in hypertrophic obstructive cardiomyopathy. Postgrad Med J 47 (Suppl): 93Google Scholar
  24. 21.
    Webb-Peploe MM (1974) Management of hypertrophic obstructive cardiomyopathy by beta-blockade. In: Wolstenhome G, O’Connor M (eds) Ciba Foundation Study Group. Churchill, London, p 103Google Scholar
  25. 22.
    Swanton RH, Brooksley I AB, Jenkins BS, Webb-Peploe MM (1977) Haemodynamic studies of beta-blockade in hypertrophic obstructive cardiomyopathy. Eur J Cardiol 5 /4: 327PubMedGoogle Scholar
  26. 23.
    De la Calzada CS, Ziady GM, Hardarson T, Curiel R, Goodwin JF (1976) Effect of acute administration of propranolol on ventricular function in hypertrophic obstructive cardio-myopathy measured by non-invasive techniques. Br Heart J 38: 798Google Scholar
  27. 23a.
    Alvares R (1980) Diastolic function and prognosis in hypertrophic cardiomyopathy. PhD thesis, University of LondonGoogle Scholar
  28. 24.
    Goodwin JF (1974) International lecture: Prospects and predictions for the cardiomyo-pathies. Circulation 50: 210PubMedGoogle Scholar
  29. 25.
    Sanderson JE, Gibson DG, Brown DJ, Goodwin JF (1977) Left ventricular filling in hypertrophic cardiomyopathy. An angiographic study. Br Heart J 39: 661Google Scholar
  30. 26.
    Sanderson JE, Traill TA, Sutton MGStJ, Brown DJ, Gibson DG, Goodwin JF (eds) Left ventricular relaxation and filling in hypertrophic cardiomyopathy, an echocardiographic study. Br Heart J 40: 596Google Scholar
  31. 27.
    Goodwin JF (1979) Cardiomyopathy: an interface between fundamental and clinical cardiology. In: Hayase, Murao (eds) Cardiology proceedings, VIII world congress of cardiology, Tokyo 1978. Excerpta Medica, Amsterdam, p 103Google Scholar
  32. 28.
    Goodwin JF, Shah PM, Oakley CM, Cohen J, Yipintosi T, Pocock W (1964) The clinical pharmacology of hypertrophic obstructive cardiomyopathy. In: Wolstenholme G, O’Connor M (eds) Cardiomyopathies. Ciba Symposium. Churchill, London, p 189Google Scholar
  33. 29.
    Braunwald E, Lambrew CT, Harrison DC, Morrow AG (1966) The haemodynamic effect of circulatory drugs in patients with idiopathic hypertrophic subaortic stenosis. In: Wolstenholme G, O’Connor M (eds)Cardiomyopathies. Ciba Symposium. Churchill, London, p 172Google Scholar
  34. 29a.
    Goodwin JF (1982) The frontiers of cardiomyopathy. Br Heart J 48: 1PubMedGoogle Scholar
  35. 29b.
    Goodwin JF (1981) In: Yu PN, Goodwin JF (eds) Future trends in cardiomyopathies, part 1. Predictions for the cardiomyopathies. Lea and Febiger, Philadelphia (Progress in cardiology, vol 10), p 175Google Scholar
  36. 29c.
    Criley JM, Lewis KB, White RI etal. (1965) Pressure gradients without obstruction. A new concept of hypertrophic subaortic stenosis. Circulation 32: 881Google Scholar
  37. 30.
    Raizner AE, Chahine RA, Ishimori T, Awdeh M (1977) Clinical correlation of left ventricular cavity obliteration. Am J Cardiol 40: 303PubMedGoogle Scholar
  38. 31.
    Brock R (1964) Hypertrophic obstruction of the left ventricular outflow: clinical recognition of the condition. In: Wolstenholme G, O’Connor M (eds) Churchill, London, p 4Google Scholar
  39. 32.
    Murgo JP, Alter BR, Dorethy JF, Altobelli SA, McGranaham GMJ jr (1980) Dynamics of left ventricular ejection in obstructive and non-obstructive cardiomyopathy. J Clin Invent 66: 1369Google Scholar
  40. 32a.
    Sugrue DD, McKenna WJ, Dickie S, Myers MJ, Lavender JP, Oakley CM, Goodwin JF (1984) Relation between left ventricular gradient and relative stroke volume ejected in early and late systole in hypertrophic cardiomyopathy. Assessment with radionuclide cineangiography. Br Heart J 52: 602Google Scholar
  41. 33.
    McKenna W, Deanfield J, Faruqui A, England D, Oakley CM, Goodwin JF (1981) Prognosis in hypertrophic cardiomyopathy: role of age and clinical electrocardiographic and haemodynamic features. Am J Cardiol 47: 532PubMedGoogle Scholar
  42. 33a.
    Pasternac A, Noble J, Streuleus V, Elie R, Heuschke C, Bourassa MG (1982) Pathophysiology of chest pain in patients with cardiomyopathies and normal coronary arteries Circulation 65: 778Google Scholar
  43. 33b.
    Thompson DS, Naquie N, Juul SM, Swanton RH, Coltart DJ, Jenkins BS,Webb-PeploeMM (1980) Effects of propranolol on myocardial oxygen consumption, substrate extraction, and haemodynamics in hypertrophic cardiomyopathy. Br Heart J 44: 488Google Scholar
  44. 33c.
    McKenna WJ, Harries L, Deanfield J (1981) Syncope in hypertrophic cardiomyopathy. Br Heart J 47: 177Google Scholar
  45. 34.
    Maron BJ, Epstein SE, Roberts WC (1979) Hypertrophic cardiomyopathy and transmural myocardial infarction without significant atherosclerosis of the extramural coronary arteries. Am J Cardiol 43: 1086PubMedGoogle Scholar
  46. 35.
    Sakamoto T, Tei C, Murayama M, Ichiyasu H, Hoda Y, Hayashi T, Amamo K (1976) Giant T wave inversion as a manifestation of asymmetrical apical hypertrophy (AAH) of the left ventricle. Jpn Heart J 17: 661Google Scholar
  47. 36.
    Hardarson T (1974) Systolic time intervals in ischaemic heart disease. Congestive cardio-myopathy and hypertrophic obstructive cardiomyopathy. PhD Thesis, University of LondonGoogle Scholar
  48. 37.
    Hubner PJB, Ziady GM, Lane GK, Hardarson T, Scales B, Oakley CM, Goodwin JF (1973) Double-blind trial of propranolol and practalol in hypertrophic cardiomyopathy. Circula-tion 40: 3Google Scholar
  49. 38.
    Shah PM, Gramiak P, Cramer DH (1969) Ultrasound localisation of left ventricular out-flow obstruction in hypertrophic obstructive cardiomyopathy. Br Heart J 36: 1Google Scholar
  50. 39.
    Shah PM, Gramiak R, Adelman AG, Wigle ED (1971) Role of echocardiography in diagnosis and haemodynamic assessment of hypertrophic subaortic stenosis. Circulation 44: 891PubMedGoogle Scholar
  51. 40.
    Tajik AJ, Giuliani ER (1974) Echocardiography observations in idiopathic hypertrophic subaortic stenosis. Proc Mayo Clin 49: 89PubMedGoogle Scholar
  52. 41.
    Henry WL, Clark CE, Epstein SE (1973) Asymmetrical septal hypertrophy. Echocardiographic identification of the pathoanatomic abnormality of idiopathic hypertrophic subaortic stenosis. Circulation 47: 225Google Scholar
  53. 42.
    Larter WE, Allen HD, Shan DJ, Goldberg SJ (1976) The asymmetrically hypertrophied septum. Further differentiation of its cause. Circulation 473: 19Google Scholar
  54. 43.
    Roeske SR, O’Rourke RA, Kelin A, Leopold G, Karliner JS (1976) Non-invasive evaluation of ventricular hypertrophy in professional athletes. Circulation 53: 19Google Scholar
  55. 44.
    Goodman DJ, Gossen RM, Popp RL (1974) Echocardiographic pseudoidiopathic hyper-trophic subaortic stenosis. Chest 66: 573PubMedGoogle Scholar
  56. 45.
    Maron BJ, Gottdiener JS, Roberts WC, Hammer WJ, Epstein SE (1979) Non-genetically determined disproportionate ventricular thickening associated with left ventricular outflow tract obstruction. Br Heart J 41: 345PubMedGoogle Scholar
  57. 46.
    Gibson DG, Traill TA, Hale RJC, Brown DJ (1979) Echocardiography features of secondary left ventricular hypertrophy. Br Heart J 41: 54PubMedGoogle Scholar
  58. 47.
    King JF, de Maria AN, Miller RR, Hilliard GK, Zelis R, Mason DT (1974) Markedly abnormal mitral valve motion without simultaneous intraventricular pressure gradient due to uneven mitralseptal contact in idiopathic hypertrophic subaortic stenosis. Am J Cardiol 34: 360Google Scholar
  59. 48.
    Gehrke J, Goodwin JF (1978) The significance of systolic anterior motion ( SAM) on the mitral valve echo pattern in hypertrophic cardiomyopathy. Clin Cardiol 1: 152Google Scholar
  60. 49.
    Rodger JC (1976) Motion of mitral valve apparatus in hypertrophic cardiomyopathy with obstruction. Br Heart J 38: 732PubMedGoogle Scholar
  61. 50.
    Doi Y, McKenna WJ, Gehrke J, Oakley CM, Goodwin JF (1980) M-mode echocardiographyin hypertrophic cardiomyopathy: diagnostic criteria and prediction of obstruction. Am J cardiol 45: 6PubMedGoogle Scholar
  62. 51.
    Gehrke J (1977) Critical appraisal of one and two dimensional echocardiography in hypertrophic cardiomyopathy. Ann Radiol 45: 609Google Scholar
  63. 52.
    Martin RP, Rakowski H, French J, Popp RL (1979) Idiopathic hypertrophic sub-aortic stenosis viewed by wide-angle, phased array echocardiography. Circulation 59: 1206PubMedGoogle Scholar
  64. 52a.
    Shapiro LM, McKenna WJ (1983) Distribution of left ventricular hypertrophy in hyper-trophic cardiomyopathy: a two-dimensional echocardiography study. J Am Coll Cardiol 2: 437PubMedGoogle Scholar
  65. 53.
    Yamaguchi H, Ishimura T, Nishiyama S, Nagasaki F, Takatsa F, Nakanishi S, Nishijo T, Umeda T, Machij K (1979) Hypertrophic cardiomyopathy with giant negative T waves (apical hypertrophy) ventriculography and echocardiography features in 30 patients. Am J Cardiol 44: 1462Google Scholar
  66. 54.
    Hardarson T, de la Calzada CS, Curiel R, Goodwin JF (1973) Prognosis and mortality of hypertrophic obstructive cardiomyopathy. Lancet 1462Google Scholar
  67. 55.
    Shah PM, Adelman AC, Wigle RD, Gobel RL, Burchell HB, Hardarson T, Curiel T, de la Calzada C, Oakley CM, Goodwin JF, Yu PN (1973) The natural and unnatural history of hypertrophic obstructive cardiomyopathy. Circulation 48 (Suppl IV): IV - 5Google Scholar
  68. 55a.
    Mekenna WJ, Krikler DM, Goodwin JF (1980) Arrhythmias in dilated and hypertrophic cardiomyopathy. Med Clin North Am 68: 983Google Scholar
  69. 56.
    Goodwin JF, Krikler D (1978) Sudden death in cardiomyopathy. Adv Cardio 25: 98Google Scholar
  70. 57.
    Maron BJ, Roberts WC, Edwards JE, McAllister HA Jr, Epstein SE (1978) Sudden death in patients with hypertrophic cardiomyopathy: characterisation of 26 patients without functional limitation. Am J Cardiol 41: 803PubMedGoogle Scholar
  71. 58.
    Maron BJ, Lipson LC, Roberts WC, Savage DD, Epstein SE (1978) Malignant hypertrophic cardiomyopathy. Identification of a subgroup of families with unusually frequent premature death. Am J Cardiol 45: 1Google Scholar
  72. 59.
    McKenna WJ, Chetty S, Oakley CM, Goodwin JF (1980) Arrhythmia in hypertrophic cardiomyopathy: exercise and 48 hour ambulatory electrocardiographic assessment with and without beta-adrenergic blocking therapy. Am J Cardiol 45: 1PubMedGoogle Scholar
  73. 60.
    Ingham RE, Mason JW, Rossen RM, Goodman DJ, Harrison DJ (1978) Electrophysiological findings in patients with idiopathic hypertrophic subaortic stenosis. Am J Cardiol 41: 811PubMedGoogle Scholar
  74. 60a.
    Doi YL, McKenna WJ, Chetty S, Oakley CM, Goodwin JF (1980) Prediction of mortality and serious ventricular arrhythmia in hypertrophic cardiomyopathy. Br Heart J 44: 150PubMedGoogle Scholar
  75. 61.
    Harmjanz D, Bottcher D, Scherlein G (1972) Correlation of electrocardiographic pattern, shape of ventricular septum and isovolumic relaxation time in irregular hypertrophic cardiomyopathy (obstructive cardiomyopathy). Br Heart J 33: 928Google Scholar
  76. 62.
    Van Dam RT, Ross JP, Durrer D (1972) Electrical activation of ventricular and intra-ventricular septum in hypertrophic cardiomyopathy. Br Heart J 34: 100PubMedGoogle Scholar
  77. 63.
    Goodwin JF, Krikler D (1976) Arrhythmia as a cause of sudden death in hypertrophic cardiomyopathy. Lancet 937Google Scholar
  78. 64.
    Krikler D, Davies MJ, Rowland E, Goodwin JF, Evans RC, Shaw DB (1980) Sudden death in hypertrophic cardiomyopathy: associated accessory atrioventricular pathways. Br Heart J 43: 245PubMedGoogle Scholar
  79. 65.
    Dreyfus LS, Haiat R, Watanabe Y, Ariaga J, Reitman MC (1971) Ventricular fibrillation, a possible mechanism of sudden death in patients with Wolf-Parkinson White Syndrome. Circulation 43: 420Google Scholar
  80. 66.
    James TN, Marshall TK (1975) Clinico-pathological correlations De Subitaneous mortibus XIII. Asymmetrical hypertrophy of the heart. Circulation 51: 1149Google Scholar
  81. 67.
    Oakley GDG, McGarry K, Limb DG, Oakley CM (1979) Management of pregnancy in patients with hypertrophic cardiomyopathy. Br Med J 1: 1749PubMedGoogle Scholar
  82. 68.
    Neufeld HN, Ongley PA, Edwards JE (1960) Combined congential subvalvar aortic stenosis and infundibular pulmonary stenosis. Br Heart J 22: 686PubMedGoogle Scholar
  83. 69.
    Daoud G, Gallagher ME, Kaplan S (1961) Muscular subaortic stenosis. Am J Cardiol 7: 860PubMedGoogle Scholar
  84. 70.
    Braunwald E, Lambrew CT, Rockoff SD, Ross J Jr, Morrow AG (1964) Idiopathic hyper-trophic subaortic stenosis. Circulation 30 (Suppl IV): 3PubMedGoogle Scholar
  85. 71.
    Maron BJ, Tajik AJ, Ruthenberg HD, Graham TP, Atwood GF, Victoria BE, Lie JT, Roberts WC (1982) Hypertrophic cardiomyopathy in infants: clinical features and natural history. Circulation 65: 7.PubMedGoogle Scholar
  86. 71a.
    McKenna WJ, Deanfield JE (1984) Hypertrophic cardiomyopathy: an important cause of sudden death. Arch Dis Child 59: 971PubMedGoogle Scholar
  87. 72.
    Emanuel R (1971) The familial incidence of idiopathic cardiomyopathy. In: Wolstenhome, O’Connor (eds) Hypertrophic obstructive cardiomyopathy. Ciba Foundation Study Group, no 37. Churchill, London, p 50Google Scholar
  88. 73.
    Hollman A, Goodwin JF, Teare D, Renwick JW (1960) A family with obstructive cardio-myopathy (asymmetrical hypertrophy). Br Heart J 22: 449PubMedGoogle Scholar
  89. 74.
    Somerville J, McDonald EL (1968) Congenital anomalies in the heart with hypertrophic cardiomyopathy. Br Heart J 30: 713PubMedGoogle Scholar
  90. 75.
    Feizi P, Farres-Brown G, Emanuel R (1978) Familial study of hypertrophic cardiomyopathy and congenital aortic valve diseases. Am J Cardiol 41: 956PubMedGoogle Scholar
  91. 76.
    Somerville J, Becu L (1978) Congenital heart disease associated with hypertrophic cardiomyopathy. Br Heart J 40: 1034PubMedGoogle Scholar
  92. 77.
    Manasek FG (1970) Histogenesis of the embryonic myocardium. Am J Cardiol 25: 149PubMedGoogle Scholar
  93. 78.
    Polani PE, Myonihan EJ (1972) Progressive cardiopathic lentigenosis. Q J Med 41: 205PubMedGoogle Scholar
  94. 79.
    Elliot CM, Tajik AJ, Giuliani ER, Gordon H (1976) Idiopathic hypertrophic subaortic stenosis associated with cutaneous neurofibromatosis: report of a case. Am Heart J 92: 368Google Scholar
  95. 80.
    Thoren C (1964) Friedreich’s ataxia with studies of cardiobascular and respiratory function. Acta Paediatr Scand 63 (Suppl): 153Google Scholar
  96. 81.
    Dargie HJ, Goodwin JF (1982) Catecholamines, cardiomyopathies and cardiac function. In: Ta PN, Goodwin JF (eds) Progress in Cardiology. Lea and Fabiger, Philadelphia, p 93Google Scholar
  97. 82.
    Blaufuss AH, Lake MM, Garner D, Ishimoto BM, Criley JM (1975) Production of ventricular hypertrophy simulating idiopathic hypertrophic subacute stenosis ( IHSS) by subhypertensive infusions of norepinephrine (ne) in the conscious dog. Clin Res 23: 77aGoogle Scholar
  98. 82a.
    Witzke DJ, Kaye MP (1976) Myocardial ultrastructural changes induced by nerve growth factor. Surg Forum 27: 295PubMedGoogle Scholar
  99. 83.
    Witzke DJ, Kaye MP (1976) Hypertrophic cardiomyopathy induced by administration of nerve growth factor. Circulation 53,54:(Suppl II) 88Google Scholar
  100. 84.
    Gutgesell HP, Spear ME, Rosenberg HS (1980) Characterisation of the cardiomyopathy in infants of diabetic mothers. Circulation 61: 441PubMedGoogle Scholar
  101. 85.
    Olsen EGJ, Symons C, Hawkey C (1977) Effect of TRIAC on the developing heart. Lancet 2: 221PubMedGoogle Scholar
  102. 86.
    Barber PV, Bray CL, Beton DC (1978) Evidence of thyroid disease in cases of hyper-trophic cardiomyopathy. Br Heart J 40: 1306PubMedGoogle Scholar
  103. 87.
    Perloff JK (1981) Pathogenesis of hypertrophic cardiomyopathy: hypotheses and specula-tions. Am Heart J 101: 219PubMedGoogle Scholar
  104. 88.
    Matsumori A, Hirose K, Wakabayshi A, Kawai C, Nakeya N, Sakurami T, Tsuji K (1979) HLA and hypertrophic cardiomyopathy. Am Heart J 97: 428PubMedGoogle Scholar
  105. 89.
    Vaughan Williams EM, Tasgal J, Raine AEG (1977) Morphometric changes in rabbit ventricular myocardium produced by long-term beta-adrenergic blockade. Lancet 2: 850Google Scholar
  106. 90.
    Nissen RC, Tajik AJ, Ciullian ER, Brandenberg RO (1978) Idiopathic hypertrophic subaortic stenosis: long-term medical follow-up (abstract). Am J Cardiol 41: 434Google Scholar
  107. 91.
    Frank MJ, Abdulla AM, Canedo MI, Sayloss RE (1978) Long-term medical management of hypertrophic obstructive cardiomyopathy. Am J Cardiol 42: 993PubMedGoogle Scholar
  108. 92.
    Cranefield PF, Armson RS, White AI (1974) The effect of verapamil on the normal actide potential and on a calcium-dependent slow response of canine fibres. Circulation 60: 11, 155Google Scholar
  109. 93.
    Rosing R, Kent KM, Maron BJ, Epstein SE (1979) Verapamil therapy: a new approach to the pharmacologic treatment of hypertrophic cardiomyopathy. I. Haemodynamic effects. Circulation 60: 1201Google Scholar
  110. 94.
    Rosing R, Kent KM, Maron BJ, Epstein SE (1979) Verapamil therapy: a new approach to the pharmacologic treatment of hypertrophic cardiomyopathy. II. Effects on exercise capacity and symptomatic status. Circulation 60: 11, 185Google Scholar
  111. 95.
    Troesch M, Hirzel NO, Jenni R, Krayenbuhl HF (1979) Reduction of septal thickness following verapamil in patients with asymmetric septal hypertrophy (ASH). Circulation 60: 11, 155Google Scholar
  112. 96.
    Epstein SE, Rosing DR (1981) Verapamil: its potential for causing serious complications in patients with hypertrophic cardiomyopathy. Circulation 64: 437PubMedGoogle Scholar
  113. 97.
    Rosenbaum MB, Chicale PA, Halpern MS, Nau GJ, Ppsykylski J, Levi RJ, Lazzari JO, Elizari MV (1976) Clinical efficiency of amiodarone as an anti-arrhythmic aid. Am J Cardiol 38: 934PubMedGoogle Scholar
  114. 98.
    Cherian G, Brockington IF, Shah PM, Oakley CM, Goodwin JF (1966) Beta-adrenergic blockade in hypertrophic obstructive cardiomyopathy. Am J Cardiol 18: 481Google Scholar
  115. 99.
    Adelman AG, Wigle ED, Randanthan N, Webb GD, Kidd BSL, Bigelow WG, Silver MD (1972) The clinical course in muscular subaortic stenosis: a retrospective and prospective study of 60 haemodynamically proven cases. Ann Intern Med 77: 515PubMedGoogle Scholar
  116. 100.
    Sowton E Beta-adreneric blocking drugs in the treatment of hypertrophic cardiomyopathy. In: Schweiger, Berne E (eds) Beta-blockers - present status and future prospects. Inter-national Symposium, Juan-les-Pins, p 230Google Scholar
  117. 101.
    Speiser KW, Krayenbuhl HP (1981) Re-appraisal of the effect of beta-blockade on left ventricular filling dynamics in hypertrophic cardiomyopathy. Eur Heart J 2: 21PubMedGoogle Scholar
  118. 101a.
    McKenna WJ, Oakley CM, Krikler DM, Goodwin JF (1984) Improved survival with amio-darone in patients with hypertrophic cardiomyopathy and ventricular tachycardia. Br Heart J 53: 412Google Scholar
  119. 102.
    McKenna WJ, England D, Doi YL, Deanfield JE, Oakley CM, Goodwin JF (1981) Arrhythmias in hypertrophic cardiomyopathy: influence on prognosis. Br Heart J 46: 168PubMedGoogle Scholar
  120. 103.
    McKenna WJ, Harris L, Perez G, Krikler DM, Oakley CM, Goodwin JF (1981) Arrhythmias in hypertrophic cardiomyopathy. II. Comparison of amiodarone and verapamil in treatment. Br Heart J 46: 173PubMedGoogle Scholar
  121. 103a.
    McKenna WJ, Harris L, Rowland E, Kleinebenne A, Krikler DM, Oakley CM, Goodwin JF (1984) Amidarone for long-term management of patients with hypertrophic cardiomyopathy. Am J Cardiol 54: 802PubMedGoogle Scholar
  122. 103b.
    Nathan AW, Hellestrand KJ, Bexton RS, Ward DE, Spurrell RAJ, Camm AJ (1982) Electrophysiological effects of sotalol-just another beta-blocker? Br Heart J 47: 515PubMedGoogle Scholar
  123. 104.
    Sobel SM, Rakita L (1982) Pneumonitis and pulmonary fibrosis associated with amiodarone treatment: a possible complication of a new anti-arrhythmic drug. Circulation 65: 819Google Scholar
  124. 104a.
    McKenna WJ, Krikler DM (1984) Clinical evaluation of the efficacy of oral amiodarone. Br Heart J 51: 241PubMedGoogle Scholar
  125. 104b.
    Lorell BH, Paulus W, Grossman W, Wynne J, Cohn PF, Braunwald E (1980) Improved diastolic function and systolic performance in hypertrophic cardiomyopathy after nifedi-pine. N Eng J Med 303: 801Google Scholar
  126. 104c.
    Lorell BH, Paulus W, Grossman W, Wynne J, Cohn PF, Braunwald E (1980) Improved diastolic function and systolic performance in hypertrophic cardiomyopathy after nifedi-pine. N Engl J Med 303: 801PubMedGoogle Scholar
  127. 104d.
    Landmark K, Sire S, Thanlow E, Amlie JP, Nitter-Haug S (1982) Haemodynamic effects of nifedipine and propranolol in patients with hypertrophic obstructive cardiomyopathy. Br Heart J 48: 19PubMedGoogle Scholar
  128. 104e.
    Wigle ED, Henderson M, Sasson C, Pollick C, Rakowski H (1985) In: Goodwin JF (ed) Muscular subactive stenosis (hypertrophic obstructive cardiomyopathies: the evidence for obstruction to left ventricular reflex in “Heart muscle disease” M.T.S. Press Lancaster, Boston, p 217Google Scholar
  129. 105.
    Morrow AG (1974) Asymmetrical septal hypertrophy. Ann Intern Med 81: 676Google Scholar
  130. 106.
    Kuhn H, Krelhaus W, Bircks W, Schulte HD, Loogen F (1978) Indications for surgical treatment in patients with hypertrophic obstructive cardiomyopathy. In: Kaltenbach M, Loogen F, Olsen EGS (eds) Cardiomyopathy and myocardial biopsy. Springer, Berlin Heidelberg New York, p 308Google Scholar
  131. 107.
    Gerbaux A, Hanania G, Godefroid J, Baragan J, Mauoad J, Gay J (1976) Results ä long terme du traitement cirurgicale de la myocardiopathie obstructive par la resection de la septum interventriculairs. Arch Mal Coeur 69: 791PubMedGoogle Scholar
  132. 108.
    Maron BJ, Merrill WH, Freier PA, Kent KM, Epstein SE, Morrow AG (1978) Long term clinical course and symptomatic status of patients after operation for hypertrophic sub-aortic stenosis. Circulation 57: 1205PubMedGoogle Scholar
  133. 109.
    Cooley DA, Leachman RD, Wukasch DC (1983) Diffuse muscular subaortic stenosis. Surgical treatment. Am J Cardial 31: 1Google Scholar
  134. 110.
    Goodwin JF (1980) Hypertrophic cardiomyopathy: a disease in search of its own identity. Am J Cardiol 45: 17Google Scholar
  135. 111.
    Rubin KA, Morrison J, Paducik MB, Binder AJ et al. (1979) Idiopathic hypertrophic subaortic stenosis; evaluation of anginal symptoms with Thallium-201 myocardiafimaging. Am J Cardiol 44: 1040PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1987

Authors and Affiliations

  • J. F. Goodwin
    • 1
  1. 1.Royal Postgraduate Medical SchoolLondonUK

Personalised recommendations